Small Business Resources, Business Advice and Forms from AllBusiness.com

Names in the News

*The United Network for Organ Sharing has elected new officers for 1998-99. They include: President - William Pfaff, MD, Shands Hospital/University of Florida, Gainesville; Vice President - William Payne, MD, Fairview-University Medical Center, Minneapolis, MN; Vice President of Patient and Donor

Family Affairs - Lynn Hill Slabaugh, The Transplant Foundation, Richmond, VA; Secretary - Phyllis Weber, California Transplant Donor Network, San Francisco, CA; Treasurer - Susan Gunderson, LifeSource, St. Paul, MN; Immediate Past President - Larry Hunsicker, MD, University of Iowa Hospital & Clinic, Iowa City; Region I Councillor - Marc Lorber, MD, Yale University School of Medicine, New Haven, CT; Region 2 Councillor - John Fung, MD, University of Pittsburgh Medical Center, Pittsburgh, PA; Region 3 Councillor - Mark Deierhoi, MD, University of Alabama Hospital, Birmingham; Region 4 Councillor - R. Patrick Wood, MD, Texas Liver Center, Houston; Region 5 Councillor - John Holman, Jr., MD, University of Utah School of Medicine, Salt Lake City; Region 6 Councillor - Christopher Marsh, MD, University of Washington Transplant Center, Seattle, WA; Region 7 Councillor -Anthony D'Alessandro, MD, University of Wisconsin Hospital, Madison; Region 8 Councillor - Charles Shields III, MD, Wichita Surgical Specialists, Wichita, KS; Region 9 Councillor - William Ramey, MD, St. Luke's-Roosevelt Hospital Center, New York, NY; Region 10 Councillor - Charles Carter, MD, Methodist Professional Center, Indianapolis, IN; Region 11 Councillor - Timothy Pruett, MD, University of Virginia HSC Transplant Program, Charlottesville; Thoracic Organ Transplant Representative - Mark Boucek, MD, The Children's Hospital, Denver, CO; Histocompatibility Representative - Patrick Beatty, MD, University of Utah Medical Center, Salt Lake City; Histocompatibility Representative - Judith Thomas, PhD, University of Alabama Hospital, Birmingham; Organ Procurement Organization Representatives - Jarold Anderson, Regional Organ Bank of Illinois, Chicago, and Dennis Heinrichs, LifeLink Foundation, Tampa, FL; Transplant Coordinator Representative - Mary Ann Palumbi, Allegheny General Hospital, Pittsburgh, PA; Transplant Coordinator Representative - Lauren Williams Todd, Nebraska Health System - South, Omaha; At Large Representatives - Patricia Adams, MD, Bowman Gray School of Medicine, Winston-Salem, NC, and Jeffrey Barnard, MD, Chief Medical Examiner Dallas County, Dallas, TX; Voluntary Health/Recipient Organizations - Scharleen Colant, PhD, San Francisco, CA, and John Newmann, PhD, Reston, VA; General Public Representatives - Margo Akerman, Knoxville, TN; A. Watson Bell, Searcy, AR; Margaret Coolican, Hartford, CT; Arlean Locicero, Hawthorne, NJ; Thealeeta Monet, Raleigh, NC; Kenneth Moritsugu, MD, Washington, D.C.; Lawrence Schkade, PhD, Arlington, TX; and Manuel Zapata, Austin, TX; Minority Transplant Representative - Denise Alveranga, MD, LifeLink Transplantation Institute, Tampa, FL; Medical/Scientific Organization Representative - Ronald Ferguson, MD, Ohio State University Medical Center, Columbus, (ASTS), and Leslie Miller, MD, University of Minnesota Department of Medicine, Minneapolis (ASTP). *Marilyn Lindenauer, president and CEO of the Midwest Eyebanks and Transplantation Center (MEBTC) in Ann Arbor, MI, announced she will retire at the end of this fiscal year. MEBTC has announced Florence Johnson has been appointed to be Lindenauer's successor. Johnson has been serving as MEBTC's senior vice president.

*Michael Phillips has been named CEO of Life Connection of Ohio, Maumee, OH. Previously, Phillips was director of the Alabama Organ Center in Birmingham. He replaces Lenora Geiger. *Michele Hooper has been named president and CEO of the Stadtlander Drug Company, Pittsburgh, PA. Previously, Hooper was corporate vice president of Caremark International, and president of Caremark International Business Group, Deerfield, IL. *Gertrude Elion has been chosen to become a member of the Women in Science and Technology (WITI) Hall of Fame. A recipient of the 1988 Nobel Prize for Physiology or Medicine, Elion is scientist emeritus with Glaxo Wellcome, Inc. She is credited with the synthesis and co-development of two of the first successful drugs for the treatment of leukemia, as well as azathioprine, a drug widely used to prevent the rejection of kidney transplants and to treat rheumatoid arthritis. The WITA Hall of Fame was launched in 1996 to recognize, honor and promote the outstanding contributions women make to the scientific and technological communities and society at large.

In addition, make sure to read these articles: